Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein
Description
Development of highly effective antivirals that are robust to viral evolution is a practical strategy for combating the continuously evolved severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Inspired by viral multistep entry process, we
